Screener
Capricor Therapeutics CAPR Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| PROPERTY AND EQUIPMENT, net | 28,502,617 | 18,312,238 | |
| OTHER ASSETS | |||
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | |
| Other assets | 1,533,591 | 1,159,480 | |
| TOTAL ASSETS | $326,283,517 | $ | $355,949,294 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES | |||
| Accounts payable | $3,927,941 | $ | $1,654,754 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's other non-current assets?
- Capricor Therapeutics (CAPR) reported other non-current assets of $1.53M in Q1 2026.
- How has Capricor Therapeutics's other non-current assets changed year-over-year?
- Capricor Therapeutics's other non-current assets increased by 505.3% year-over-year, from $253.37K to $1.53M.
- What is the long-term trend for Capricor Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), Capricor Therapeutics's other non-current assets has grown at a 67.2% compound annual growth rate (CAGR), from $88.7K to $1.16M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Capricor Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude